Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Diversity of degradation signals in the ubiquitin-proteasome system.

Ravid T, Hochstrasser M.

Nat Rev Mol Cell Biol. 2008 Sep;9(9):679-90. doi: 10.1038/nrm2468. Review.

2.
3.

Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency.

Lucchiari S, Santoro D, Pagliarani S, Comi GP.

Acta Myol. 2007 Jul;26(1):72-4.

4.

A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.

Cheng A, Zhang M, Gentry MS, Worby CA, Dixon JE, Saltiel AR.

Genes Dev. 2007 Oct 1;21(19):2399-409.

5.

Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre.

Bennett-Lovsey RM, Herbert AD, Sternberg MJ, Kelley LA.

Proteins. 2008 Feb 15;70(3):611-25.

PMID:
17876813
6.
7.

Role of ubiquitin- and Ubl-binding proteins in cell signaling.

Kirkin V, Dikic I.

Curr Opin Cell Biol. 2007 Apr;19(2):199-205. Epub 2007 Feb 15. Review.

PMID:
17303403
8.

CAP interacts with cytoskeletal proteins and regulates adhesion-mediated ERK activation and motility.

Zhang M, Liu J, Cheng A, Deyoung SM, Chen X, Dold LH, Saltiel AR.

EMBO J. 2006 Nov 15;25(22):5284-93. Epub 2006 Nov 2.

9.

Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

Gentry MS, Worby CA, Dixon JE.

Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8501-6. Epub 2005 Jun 1.

10.

Fluorogenic substrates of glycogen debranching enzyme for assaying debranching activity.

Watanabe Y, Makino Y, Omichi K.

Anal Biochem. 2005 May 15;340(2):279-86.

PMID:
15840501
11.

Molecular characterization of glycogen storage disease type III.

Shen JJ, Chen YT.

Curr Mol Med. 2002 Mar;2(2):167-75. Review.

PMID:
11949933
12.

A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen.

Wang J, Stuckey JA, Wishart MJ, Dixon JE.

J Biol Chem. 2002 Jan 25;277(4):2377-80. Epub 2001 Dec 5.

13.

Identification of the catalytic residues of bifunctional glycogen debranching enzyme.

Nakayama A, Yamamoto K, Tabata S.

J Biol Chem. 2001 Aug 3;276(31):28824-8. Epub 2001 May 25.

14.

Aggresomes, inclusion bodies and protein aggregation.

Kopito RR.

Trends Cell Biol. 2000 Dec;10(12):524-30. Review.

PMID:
11121744
15.

Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.

Okubo M, Horinishi A, Takeuchi M, Suzuki Y, Sakura N, Hasegawa Y, Igarashi T, Goto K, Tahara H, Uchimoto S, Omichi K, Kanno H, Hayasaka K, Murase T.

Hum Genet. 2000 Jan;106(1):108-15.

PMID:
10982190
16.

Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.

Okubo M, Kanda F, Horinishi A, Takahashi K, Okuda S, Chihara K, Murase T.

Hum Mutat. 1999 Dec;14(6):542-3.

PMID:
10571954
17.

The subgroups of type 3 glycogenosis.

Van Hoof F, Hers HG.

Eur J Biochem. 1967 Oct;2(3):265-70. No abstract available.

18.

Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.

Ding JH, de Barsy T, Brown BI, Coleman RA, Chen YT.

J Pediatr. 1990 Jan;116(1):95-100.

PMID:
2295969
19.

Reassessment of the catalytic mechanism of glycogen debranching enzyme.

Liu W, Madsen NB, Braun C, Withers SG.

Biochemistry. 1991 Feb 5;30(5):1419-24.

PMID:
1991122
20.

Debranching enzyme from rabbit skeletal muscle. Purification, properties and physiological role.

Taylor C, Cox AJ, Kernohan JC, Cohen P.

Eur J Biochem. 1975 Feb 3;51(1):105-15.

Supplemental Content

Support Center